Biggest News Aggregation in the World
📰 Published September News

Published September News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Published September. Real-time updates on events, politics, business and more.

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT

PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...
United States European Commission Decision Pfizer Inc Drug Administration Exchange Commission European Union

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

NEW YORK, March 13, 2024--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.
United States European Union European Commission Exchange Commission National Center Drug Administration
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science